Sections

Home | Cancers | Lung Cancer

Lung Cancer

Scientists find lethal vulnerability in treatment-resistant lung cancer

DALLAS – Researchers working in four labs at UT Southwestern Medical Center have found a chink in a so-called “undruggable” lung cancer’s ...

Liquid Biopsy: Level of mutated DNA in the blood corresponds to patient outcome

New findings from a scientific collaboration between the German Cancer Research Center (DKFZ), the National Center for Tumor Diseases (NCT) Heidelberg and ...

Drug-loaded synthetic nanoparticles can distinguish lung cancer cells from healthy cells

DALLAS – Researchers with the Harold C. Simmons Comprehensive Cancer Center successfully developed a synthetic polymer that can transport a drug into lung cancer cells without going inside of normal lung cells. ... Full story

Case for Liquid Biopsies Builds in Advanced Lung Cancer

Penn Study Addresses Unmet Need for Better, Non-Invasive Tests Called Out in Recent "Moonshot" Blue Ribbon Panel Report ... Full story

Research questions whole brain radiotherapy for older lung cancer patients

Older lung cancer patients whose disease has spread to the brain could be spared potentially harmful radiotherapy, new research indicates. ... Full story

Lung cancer screening trial

The introduction of lung cancer screening in the UK could significantly reduce deaths in high risk groups, without causing participants the undue stress sometimes associated with medical tests. ... Full story

Scientists discover new therapeutic target for lung cancer driven by KRAS

DALLAS – UT Southwestern Medical Center researchers have identified a new way to target lung cancer through the KRAS gene, one of the most commonly mutated genes in human cancer and one researchers have so far had difficulty targeting successfully. ... Full story

New therapeutic targets for small cell lung cancer identified

DALLAS – UT Southwestern Medical Center researchers have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming. ... Full story

Hybrid Immune Cells in Early-Stage Lung Cancer Spur Anti-Tumor T Cells to Action

PHILADELPHIA - The microenvironment of tumors is a mix of cell types, mostly comprised of inflammatory cells. White blood cells, recruited from the blood and bone marrow, represent a significant portion of these inflammatory cells and influence nearly all steps of tumor progression. One type, called tumor associated neutrophils (TANs), predominates; however, the role of TANs in tumor development remains largely unexplored in humans. ... Full story

Revolutionary surgery for lung cancer

Montreal – The University of Montreal Hospital Research Centre (CRCHUM) is launching a major international clinical trial to test a minimally invasive and safer surgical approach for patients with lung cancer: video-assisted thoracoscopic (VATS) lobectomy with ultrasonic pulmonary artery sealing. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 198 | displaying: 1 - 10